VAERS reports by lot

GSK Varicella/Shingles lot H4H34: VAERS reports

34 VAERS reports list lot H4H34 as a GSK Varicella/Shingles vaccine, received between 2020-04-17 and 2023-07-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
34
Reports
3%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)2223%
Injection-site / Local reaction2122%
General / Systemic (non-local)1920%
Neurological88%
Gastrointestinal66%
Musculoskeletal66%
Cardiac / Cardiovascular55%
Allergic / Anaphylactic33%
Respiratory33%
Psychiatric / Neuropsychiatric33%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Pennsylvania5
Ohio4
New York3
Georgia2
Virginia2
Michigan2
New Hampshire2
Connecticut1
Utah1
Tennessee1
Kansas1

Reports by month received

2020-041
2020-051
2020-064
2020-073
2020-082
2020-091
2020-102
2020-118
2020-121
2021-013
2021-021
2021-031
2021-052
2021-061
2021-111
2021-121
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.